检验医学 ›› 2018, Vol. 33 ›› Issue (2): 106-109.DOI: 10.3969/j.issn.1673-8640.2018.02.003

• 临床应用研究_论著 • 上一篇    下一篇

0~3岁婴幼儿凝血功能参考区间的建立

邹琛, 高原   

  1. 上海市儿童医院检验科,上海 200062
  • 收稿日期:2016-10-05 出版日期:2018-02-28 发布日期:2018-03-02
  • 作者简介:null

    作者简介:邹琛,女,1992年生,学士,技师,主要从事临床检验工作。

Establishment of the reference intervals of coagulation function in 0-3-year-old children

ZOU Chen, GAO Yuan   

  1. Department of Clinical Laboratory,Children's Hospital of Shanghai,Shanghai 200062,China;
  • Received:2016-10-05 Online:2018-02-28 Published:2018-03-02

摘要:

目的 建立0~3岁婴幼儿凝血功能参考区间。方法 对966例0~3岁婴幼儿凝血功能进行检测,要求被检测婴幼儿无发热、炎症、血液病、消化系统疾病、呼吸系统疾病、内分泌疾病,无肿瘤或其他遗传性疾病,生长发育正常。分别统计凝血酶原时间(PT)、凝血酶原时间国际标准化比值(PT-INR)、活化部分凝血活酶时间(APTT)、纤维蛋白原(Fib)、凝血酶时间(TT)等参数。将研究对象按年龄分为围产期新生儿组(0~7 d)、新生儿组(8~30 d)、婴幼儿组1(1~6个月)、婴幼儿组2(7~12个月)、幼儿组1(1~2岁)和幼儿组2(2~3岁)。分别对上述各项参数进行统计学分析,得到各项参数的参考区间。结果 1~6 个月与7~12个月,1~2岁与2~3岁PT差异无统计学意义(P>0.05),合并后得PT的参考区间:0~7 d为12.20~15.08 s、8~30 d为11.84~14.20 s、1~12个月为11.05~13.45 s、1~3岁为10.92~12.68 s;PT-INR的参考区间:0~7 d为1.07~1.45、8~30 d为0.99~1.27、1~12个月为0.82~1.10、1~3岁为0.83~1.10。0~7 d与8~30 d、7~12个月与1~2岁、2~3岁APTT差异无统计学意义(P>0.05),合并后得APTT的参考区间:0~30 d为21.27~58.20 s、1~6个月为24.67~51.52 s、7个月~3岁为24.01~43.73 s。8~30 d与1~6个月,7~12个月与1~2岁、2~3岁Fib差异无统计学意义(P>0.05),合并后得Fib的参考区间:0~7 d为1.43~3.97 g/L、8 d~6个月为1.58~3.72 g/L、7个月~3岁为2.65~3.89 g/L。0~7 d与8~30 d、1~6个月,7~12个月与1~2岁、2~3岁TT差异无统计学意义(P>0.05),合并后得TT的参考区间:0 d~6个月为15.31~24.83 s、7个月~3岁为15.83~23.39 s。结论 婴幼儿的凝血功能处于一个不断健全的过程,各凝血功能指标均存在生理变化。建议各实验室按不同年龄建立合适的参考区间,为临床诊治凝血系统疾病、术前检查、抗凝药物监测等提供准确的判断依据。

关键词: 凝血功能, 新生儿, 婴幼儿, 参考区间

Abstract:

Objective To establish the reference intervals of coagulation function in 0-3-year-old children. Methods Coagulation function was determined in 966 children of 0-3-year-old. The children were required without fever,inflammation,hematological diseases,digestive diseases,respiratory diseases,endocrine diseases,tumor or other genetic diseases and with normal growth. Prothrombin time(PT),prothrombin time international normalized ratio(PT-INR),activated partial thromboplastin time(APTT),fibrinogen(Fib) and thrombin time(TT) were determined. According to age,the 966 children were classified into perinatal newborn (0-7 d),newborn(8-30 d),infant 1(1-6 months),infant 2(7-12 months),child 1(1-2 years) and child 2(2-3 years) groups. The parameters were analyzed statistically,and the reference intervals were evaluated. Results PT showed no statistical significance between 1-6 months and 7-12 months and between 1-2 years and 2-3 years old groups(P>0.05). PT were 12.20-15.08s for 0-7 d,11.84-14.20s for 8-30 d,11.05-13.45s for 1-12 months and 10.92-12.68s for 1-3 years. PT-INR were 1.07-1.45 for 0-7 d,0.99-1.27 for 8-30 d,0.82-1.10 for 1-12 months and 0.83-1.10 for 1-3 years. APTT showed no statistical significance between 0-7 d and 8-30 d,between 7-12 months and 1-2 years and between 7-12 months and 2-3 years old groups(P>0.05). APTT were 21.27-58.20s for 0-30 d,24.67-51.52s for 1-6 months and 24.01-43.73s for 7 months-3 years. Fib showed no statistical significance between 8-30 d and 1-6 months,between 7-12 months and 1-2 years and between 7-12 months and 2-3 years old groups(P>0.05). Fib were 1.43-3.97g/ L for 0-7 d,1.58-3.72g/L for 8 d-6 months and 2.65-3.89g/L for 7 months-3 years. TT showed no statistical significance between 0-7 d and 8-30 d,between 0-7 d and 1-6 months,between 7-12 months and 1-2 years and between 7-12 months and 2-3 years old groups(P>0.05). TT were 15.31-24.83s for 0 d-6 months and 15.83-23.39s for 7 months-3 years. Conclusions Children's coagulation function is in a continuous growing process. There are physiological changes for each parameter of coagulation function. Laboratories should establish suitable reference intervals according to age,in order to provide a reference for clinical diagnosis and treatment of coagulation system diseases,preoperative examination and anticoagulant monitoring.

Key words: Coagulation function, Newborn, Infant, Reference interval

中图分类号: